Catalyst Wire Dossier Catalyst Wire Dossier

Transdermal Contraceptive System

ethinyl estradiol / norelgestromin · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Transdermal Contraceptive System, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil. [Phase 3]

See pricing